TMC Life Sciences Bhd (XKLS:0101) 3-Year RORE % : 35.43% (As of Mar. 2026)


XKLS:0101 TMC Life Sciences Bhd XKLS:0101
60 GF Score
Price RM0.47
GF Value RM0.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd 3-Year RORE %?

TMC Life Sciences Bhd XKLS:0101 +1.09% 60 3-Year RORE % is 35.43 as of Mar. 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 60/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 606 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks better than 79.54% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. TMC Life Sciences Bhd's 3-Year RORE % for the quarter that ended in Mar. 2026 was 35.43%.

The industry rank for TMC Life Sciences Bhd's 3-Year RORE % or its related term are showing as below:

XKLS:0101's 3-Year RORE % is ranked better than
79.54% of 606 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs XKLS:0101: 35.43

TMC Life Sciences Bhd  (XKLS:0101) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


TMC Life Sciences Bhd 3-Year RORE % Related Terms


TMC Life Sciences Bhd 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd 3-Year RORE % Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 21.15 103.82 1.33

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139.20 1.33 1.58 1.58 35.43

XKLS:0101 vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's 3-Year RORE % falls into.


XKLS:0101
60GF Score
TMC Life Sciences Bhd XKLS:0101
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd 3-Year RORE % Calculation

TMC Life Sciences Bhd's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.009-0.595 )/( -1.643-0.011 )
=-0.586/-1.654
=35.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 35.43 mean?
TMC Life Sciences Bhd (XKLS:0101) has a 3-Year RORE % of 35.43 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on TMC Life Sciences Bhd and its competitors. According to the industry distribution chart, TMC Life Sciences Bhd ranks #124 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 20.5%.
Is TMC Life Sciences Bhd's 3-Year RORE % too high?
TMC Life Sciences Bhd's current 3-Year RORE % is 35.43. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. TMC Life Sciences Bhd's value of 35.43 is 18069.2% above this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #124 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, TMC Life Sciences Bhd has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #124 out of 606 companies for 3-Year RORE %. This places TMC Life Sciences Bhd in the top 21% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.20. TMC Life Sciences Bhd's value of 35.43 is 18069.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current 3-Year RORE % of 35.43 is 18069.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current 3-Year RORE % is 35.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.47 — trading 25% below its estimated fair value. The current 3-Year RORE % is 35.43 and 18069.2% above the Healthcare Providers & Services industry median of 0.20. TMC Life Sciences Bhd's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current 3-Year RORE % is 35.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.47 is trading 25% below its estimated GF Value™ of RM0.62. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • 3-Year RORE %: 35.43
  • GF Value™: RM0.62 vs. price of RM0.47 (25% below fair value)
  • GF Score™: 60/100 with 3 warning signs
  • Industry Position: 18069.2% above the Healthcare Providers & Services median (#124 of 606)

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
60GF Score

Get the complete analysis for XKLS:0101

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.47
Price
RM0.62
GF Value